Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PPS is currently trip 7- exposure is nil on ARGA
hopefully a merger
Wait until the third quarter of this year. We have big announcements that will be market changing.
message no.4
http://www.cafepharma.com/boards/showthread.php?t=362094
looks like somethin is up the way is trading life coincidence ?
some interest here chart starting to looks very good :) http://stockcharts.com/charts/gallery.html?arga
nice volume today
But when you type a msg
and click on the board it comes up
sorry
MK
what? but the symbol is not argae
LG msg board not coming up
cause when you type in ARGA
it comes up as ARGAE
MK
could be but who knows, hoping for some movement any day now
i can`t believe thats a clean shell now
imo
technically yes since golden cross is next week imho, this could have gone back to a shell status
it was a shell before arga labs took over it
second quarter 2008!?
still in play?
next week is golden cross most likely
not yet, we need to trade higher than .002 for sure to get that to happen
if crossed MA 50 and MA 200!???
golden cross any moment now
ibox fixed by admin, Liquadd image/link is now showing, I couldn't get them to show up since the last update
thx for your PM life! watchful!!
not really familiar with cdiv
NICE! was there any other reasons for this run?
do you notice the similarity in chart formation between CDIV and ARGA? CDIV has been running like crazy since that golden crossover
first time it closed at .003 in months, this reminds me of LIPD except ARGA is not in Chapter 7 like LIPD
A.T.S. Pharmaceuticals, A Division of Auriga Laboratories, Launches Zytopic(TM) Cream for the...
Publication: Business Wire
Date: Wednesday, October 31 2007
You are viewing page 1
LOS ANGELES -- Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company building the first nationwide, commission-only pharmaceutical sales force, announced today the launch of Zytopic[TM] Cream convenience kit that contains Zytopic[TM] Cream (triamcinolone, USP 0.1%), as well as Clere[TM], a soap free cleanser, and Emolene[TM], a hypoallergenic moisturizer. The introduction of this brand adds to the current ATS portfolio which also includes Akurza[TM] Cream & Lotion (Salicylic Acid 6%), and the brand Xyralid[TM] (lidocaine HCl /hydrocortisone acetate) brand.
http://www.allbusiness.com/medicine-health/diseases-disorders-immune-system/5303234-1.html
FDA Approved Drug March 10, 2008...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=37612654
hmmmm, what i said, very odd!
I've been trying to add Liquad in ibox but it's not showing it at all
when I try to edit it, it shows up after saving it, and check the ibox....it's not there
ibox edit is screwed up
probably changed, not in service lol
™, please contact Auriga Laboratories at 1-866-367-8796.
is it possble to contact them?
here's the product launched last year http://www.liquadd4kids.com/
its a lill bit odd all. quite before the calm!? ;)
Aquoral is now marketed by http://www.bicoastalpharm.com
could be a nice merger candidate?
the homepage doesnt exist. merger candidate!?
Auriga still shows up in ZINK http://zinxlozenges.com/
they still market Extendryl...checkout this link...
bottom of the page says Auriga
http://www.extendrylrx.com/
interesting post on something coming 3rd quarter....
Re: Does Auriga Still Exist?
--------------------------------------------------------------------------------
Quote:
Originally Posted by Anonymous
I would not be hopeful of a call back. Seriously I would continue your job search elsewhere. The company laid everyone off. They don't even have an office anymore. look back at the 15th of January, pretty much the last of the directors and Corporate officers quit.
Auriga will survive and thrive. Wait until the third quarter of this year. We have big announcements that will be market changing.
message no.4
http://www.cafepharma.com/boards/showthread.php?t=362094
nice! hope there is something in background. did we hear anything from company last months?
nice 1.22 for 200MA on the weekly chart
I grabbed some more at .0016 a few days ago
dont think so, volume to small
is this ready or what?
I didn't like that small bidwhack at all
hey life,
whats volume so far?
hey nice uptick .0015x.002 golden cross around the corner imho
there's still that consistent bidwhacker
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
308
|
Created
|
02/23/07
|
Type
|
Free
|
Moderators |
Auriga Laboratories
Auriga Laboratories™ develops pharmaceutical products based on patented drug delivery technologies in cellular biology, material science, and pharmaceutics. It offers Extendryl, which is used for the treatment of cough and cold medications, and allergy symptoms. The company also offers products for the treatment of gastrointestinal disorders and central nervous system disorders, including pain control. Auriga Laboratories is based in Norcross, Georgia. Auriga Laboratories™ is a specialty pharmaceutical company building an industry changing commission based-sales model. The company's high-growth business model combines driving revenues through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline, all of which is designed to enhance its growing direct relationships with physicians nationwide.
Auriga Laboratories™ Inc. is a sales-focused specialty pharmaceutical company capitalizing on high-revenue markets and opportunities in the pharmaceutical industry through a variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline. We are currently focused on delivering unique solutions for the respiratory, dermatology, and xerostomia (dry mouth) markets and enhancing our relationships with physicians nationwide.
Auriga's founders and management team are experts in managing the full life cycle of bringing a new medication to market - from pipeline development and formulation to final sales. Our drug development pipeline leverages novel material science and advanced drug delivery technologies to produce improved formulations of successful brands to further expand markets and sales for proven, successful products.
Auriga Milestones:
Computershare Trust Company, Inc.
350 Indiana Street, Suite 800
Golden, CO 80401
Share Structure
250,000,000 Shares Authorized
79,536,557 Outstanding Shares as of May 12, 2008
Company Website
http://www.aurigalabs.com
Investor Relations
805-437-7200
investors@aurigalabs.com
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |